(Reuters) -Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight ...

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

Losing weight is a huge achievement, but what about the loose skin that can come after? In this Houston Life segment, we sit ...

Here's how to stay in a deficit safely. If you’re trying to lose weight, it’s natural to want an efficient solution. During ...

Danone is introducing an Oikos brand drink targeting U.S. consumers using weight loss medications such as Wegovy, pledging ...

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight ...

Orforglipron, the new weight loss pill manufactured by Eli Lilly, helped patients in a recent study lose a significant amount ...

Women with obesity who participated in a supported weight loss program before IVF had 47 percent higher chances of getting ...

Weight-loss drugs are expected to pull in more than $150 billion in industry-wide revenue by the early 2030s, thanks to the ...

The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the ...